NCEL NewcelX Ltd.

$3.17 -2.62%

Healthcare · Pharmaceutical Preparations

NewcelX Ltd. (NCEL) is a healthcare company in the Pharmaceutical Preparations industry. Shares last traded at $3.17, 61.4% below their 52-week high.

Market Cap

—

Shares Out

—

EPS (TTM)

$2.16

P/E Ratio

1.47

P/S Ratio

—

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.19

52-Week Low

$1.90

Volume

1,215

Avg Vol (3m)

820.46

Performance

-1.09%

-5.38%

+20.34%

-9.05%

YTD

+55.15%

—

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

47.34

SMA (50)

$3.09

SMA (200)

—

Price vs SMA50

+2.32%

Price vs SMA200

—

ATR (14)

$0.19

Financials

Revenue

—

Net Income

$-8M

Gross Margin

—

Operating Margin

—

Net Margin

—

Return on Equity

-114.5%

Return on Assets

-72.5%

Current Ratio

0.76

Debt / Equity

0.00

Revenue Growth (YoY)

—

Pharmaceutical Preparations peers

NCEL vs 14 industry peers (Pharmaceutical Preparations), by market cap.

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.